Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Asthma
Sort By
Newest First
1 / 1
1 / 1
Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Robert Clarke, Ph.D
Kinaset Therapeutics
PAO-02-022-CL-13
Mar 12, 2022
Clinical Data
New Fasenra® Data from the Meltemi Extension Trial Confirm Long-term Safety and Efficacy in Severe Eosinophilic Asthma for up to Five Years
AstraZeneca
PR-M06-21-004
Jun 02, 2021
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
LEO Pharma
PR-M04-20-NI-023
Apr 15, 2020
GSK's Asthma Biologic Approved
GSK
PR-M04-20-NI-007
Apr 03, 2020
Asthma
Asthma Patients in Europe Will Have Access to a Self-Administered Syringe
Pharma's Almanac
PAO-M08-19-NI-031
Aug 22, 2019
Asthma
GSK Has Hopes for Trelegy in Asthma
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-011
May 10, 2019
Market Prediction
Global $1.82 Billion Asthma Spacers Market Outlook, 2026
ResearchandMarkets
PR-M04-19-NI-083
Apr 26, 2019
Clinical Study
Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at 2018 Annual Scientific Meeting
Pulmatrix
PR-M11-18-NI-063
Nov 19, 2018
FDA Approval
FDA Approves Asthma Indication for Dupixent® (dupilumab)
Regeneron
PR-M10-18-NI-090
Oct 25, 2018
Breakthrough Therapy
Breakthrough Therapy Designation for New Asthma Drug
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-008
Sep 13, 2018
Approval
European Commission Expands Marketing Approval for GSK’s Relvar Ellipta
Emilie Branch
Pharma's Almanac
PAO-M03-18-NI-013
Mar 15, 2018
FDA Approval
AstraZeneca’s Anti-Asthma FASENRA Wins FDA Approval
Nice Insight
PAO-M11-17-NI-038
Nov 23, 2017
Clinical Trials
GSK and Innoviva Present Positive Results from Pioneering Asthma Study
Nice Insight
PAO-M09-17-NI-020
Sep 19, 2017
